4//SEC Filing
Zangerle John Adam 4
Accession 0001628280-25-052076
CIK 0001757898other
Filed
Nov 12, 7:00 PM ET
Accepted
Nov 13, 4:34 PM ET
Size
9.3 KB
Accession
0001628280-25-052076
Insider Transaction Report
Form 4
STERIS plcSTE
Zangerle John Adam
Sr. VP, Gen Counsel, and Sec.
Transactions
- Sale
Ordinary Shares
2025-11-11$265.14/sh−15,000$3,977,100→ 33,669 total - Exercise/Conversion
Ordinary Shares
2025-11-11$69.72/sh+15,000$1,045,800→ 48,669 total - Exercise/Conversion
Employee Stock Option (right to buy)
2025-11-11−15,000→ 0 totalExercise: $69.72Exp: 2026-06-01→ Ordinary Shares (15,000 underlying)
Footnotes (3)
- [F1]As of November 11, 2025, 8,511 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,157 on June 1, 2026; 846 on June 2, 2026; 1,252 on June 3, 2026; 1,376 on June 4, 2026; 1,252 on June 3 2027; 1,376 on June 4, 2027 and 1,252 on June 5, 2028.
- [F2]Price reflects a weighted average sale price for multiple transactions ranging from $265.00 to $265.95 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- [F3]This option to purchase 15,000 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 15,000 ordinary shares for $69.72 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option.
Documents
Issuer
STERIS plc
CIK 0001757898
Entity typeother
Related Parties
1- filerCIK 0001578804
Filing Metadata
- Form type
- 4
- Filed
- Nov 12, 7:00 PM ET
- Accepted
- Nov 13, 4:34 PM ET
- Size
- 9.3 KB